在患有急性冠状动脉综合征的患者中,胺动力学的预后价值
Elena Usova1, Alexey Yakovlev1, Georgy Kopanitsa1
1Almazov National Medical Research Centre, Saint-Petersburg, Russia.
Studies in health technology and informatics
|November 22, 2024
概括
在急性冠状动脉综合征 (ACS) 后,胺水平的变化,特别是Cer18:1/18:0,预测了复发事件. 监测这些脂质动态为心血管并发症提供了新的预后见解.
科学领域:
- 心血管医学 心血管医学
- 利皮多米克 (Lipidomics) 是一种消化剂.
- 生物化学 生物化学
背景情况:
- 心血管并发症,如复发性事件,在急性冠状动脉综合征 (ACS) 之后构成重大风险.
- 脂类的一类 - - 胺被认为与心血管病理生理学有关,但它们的动态变化和在ACS患者的预后价值需要进一步研究.
研究的目的:
- 评估胺度的预后意义及其在患有ACS的患者的时间动态.
- 评估特定胺的预测价值 (Cer18:1/16:0),Cer18:1/18:0,Cer18:1/24:1,Cer18:1/24:0) 结合复发性心血管事件的临床参数.
主要方法:
- 一项涉及110名ACS患者的前性研究.
- 在入院时,第三天和3个月的随访后,使用高性能液体染色学-并联质谱法 (HPLC-MS/MS) 进行针对性脂质组分析的三次血液采样.
- 分析胺度及其随着时间的变化与复发事件风险相关的分析.
主要成果:
- 陶胺度 (Cer18:1/16:0),Cer18:1/18:0,Cer18:1/24:1,Cer18:1/24:0) 在入院时是最高的,在入院3天和3个月的随访期间下降.
- 从入院到退院3个月后,Cer ((d18:1/18:0) 水平的变化是复发事件的强有力的独立预测因子,无论之前是否使用他类药物.
- 根据血糖状况,Cer(d18:1/18:0) 动态的预后关联 (从第3天到入院的变化) 不同.
结论:
- 胺度的动态变化,特别是Cer18:1/18:0,对于ACS患者的复发事件具有显著的预后价值.
- 监测胺样本为心血管疾病风险分层和个性化管理策略提供了潜在的工具.
- 陶胺动力学与血糖控制之间的相互作用需要进一步研究,以进行全面的心血管风险评估.
更多相关视频
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
3.4K
05:07Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
946
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
103
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
103
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
59
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
59
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
3
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3